ORT.13 -Establishment of 3D culture of mammary tumor cells for in vitro therapeutic response studies targeting personalized anticancer therapy
Introduction: Breast cancer is the second most common type of cancer in the world. Personalized therapy is an option in the fight for the cure of cancer, since tumor variability is a great challenge in the elaboration of therapeutic protocols. Only 5% of the compounds tested in vitro in 2D systems present in vivo antitumor activity. Otherwise, the three-dimensional (3D) cell culture systems, which better mimic the architecture and tumor behavior observed in vivo, respond to in vitro treatment in a similar way to tumors in patients when treated with the same chemotherapeutic agents, showing great potential for evaluation of specific tumor therapy.
Objective: The aim of this study is to evaluate the similarity of tumor spheroids produced in vitro with their original tumors, as regards the morphological, molecular and functional characteristics for therapeutic response studies, aiming at personalized anticancer therapy.
Methodology: First, we established the 3D culture with the MCF7 human breast cancer cell line and analyzed spheroid growth, death (7-AAD) and migration during doxorubicin or betalapachone treatment. At this point, we started to standardize the 3D culture with breast cancer cells from patients. Then we will perform molecular and functional analyzes. The molecular characterization will be done by analyzing the gene expression of mammary tumor biomarkers. Functional analyzes of the spheroids will be done through evaluation of proliferation, death and cell viability to compare with the pathological response after neoadjuvant therapy.
Results:
Our preclinical results demonstrate that it is possible to produce tumor spheroids both from cell lines and tumors isolated from mouse. The treatment of spheroids with doxorubicin or beta-lapachone were able to inhibit spheroid growth, induce apoptosis and inhibit metastasis in vitro.
